We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

122 hedge funds and large institutions have $332M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 48 increasing their positions, 25 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 25

41% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 22

7% more funds holding

Funds holding: 114 → 122 (+8)

8% less capital invested

Capital invested by funds: $361M → $332M (-$29.3M)

20% less call options, than puts

Call options by funds: $2.74M | Put options by funds: $3.4M

Holders
122
Holders Change
+8
Holders Change %
+7.02%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
48
Reduced
25
Closed
22
Calls
$2.74M
Puts
$3.4M
Net Calls
-$667K
Net Calls Change
+$999K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$10.6M
2
TI
tru Independence
Oregon
+$2.88M
3
BlackRock
BlackRock
New York
+$2.7M
4
GAI
General American Investors
New York
+$1.81M
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$25.2M
2
Two Sigma Investments
Two Sigma Investments
New York
-$5.49M
3
Millennium Management
Millennium Management
New York
-$5.39M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.31M
5
Rafferty Asset Management
Rafferty Asset Management
New York
-$1M

VBIV Hedge Fund Activity: Q4 2020 in Review

122 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q4 2020, worth a combined $332M — down 8.1% from $361M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new VBIV positions and 22 closed out — a net gain of 9 holders — while 48 added to existing stakes and 25 trimmed.

The largest buyer was State Street, adding an estimated $10.6M. The largest seller was Viking Global Investors, exiting entirely with an estimated $25.2M sold.

  • 122 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q4 2020, up from 114 in Q3 2020.
  • Funds reported $332M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q4 2020, down 8.1% quarter-over-quarter.
  • 31 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q4 2020 and 22 closed out, a net change of +9 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q4 2020 was State Street, an estimated $10.6M added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q4 2020 was Viking Global Investors, an estimated $25.2M sold.

Based on aggregated 13F filings for Q4 2020.